For appointments
Visit Website for more Information
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish
Telemedicine Consult Services via Folsom Gastromed
Telemedicine Consult Services
WHO:
Dr. Gish is a Hepatologist specializing in all forms of liver disease, liver cancer and liver transplant. Dr. Gish has partnered with TeleMed2U to provide telemedicine consultative services for patients with liver disease.
WHAT:TeleMed2U is a telemedicine-based multi-specialty clinical practice increasing access to specialist providers providing, “healthcare anywhere and everywhere.” The telemedicine consultation will be conducted through our HIPAA and HITECH compliant platform. Connectivity testing will be done in advance to ensure you can connect via our telemedicine platform. Following the consultation, a clinical note will be provided including a summary of your liver consultation with Dr. Gish and his consultative recommendations.
COST:Payment will be processed through an online secure transaction portal. The fees for consultative services are:
- Initial 60 minute consultation per patient: $500.00
- Follow Up 30 minute consultation per patient: $300.00
If you’d like to continue, please click Next to complete the form and we will contact you to schedule connectivity testing. During the test you will have the opportunity to determine the method of providing medical records, discuss appointment availability as well as discuss any additional questions that you have. If you are a healthcare facility interested in services, please complete the form and we can discuss the options that are right for you and your patients.
Powered by
Providing Medical Consulting Services to Pharma, CME Organizations, Academic and Private Institutions
Robert Gish, MD formed the medical consulting firm Robert G. Gish Consultants LLC in 2013 to assist liver and liver transplant programs with their operational, outreach, compliance, financial planning and program development.
His firm also provides consultations with Pharma and a means of interaction between the pharmaceutical industry and CME organizations in addition to promoting liver health policies throughout the world.
Blog
Global prevalence of hepatitis B in 2022: a modelling study
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
On-treatment risks of cirrhosis and hepatocellular carcinoma
On-treatment risks of cirrhosis and hepatocellular carcinoma among a large cohort of predominantly non-Asian patients with non-cirrhotic chronic hepatitis B
Pathway to global elimination of hepatitis B: HBV cure is just the first step
Pathway to global elimination of hepatitis B: HBV cure is just the first step
Guidelines for the Prevention and Treatment of Chronic Hepatitis B
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)
Consulting Expertise
Institutions & Industry
Improve liver centers and liver transplant programs. Overseeing implementation of eConsult systems, developing guidelines and protocols for managing liver patients and liver transplants.
Learn More
Providers & Clinicians
Services for providers and clinicians who work in the domain of liver health, including gastroenterologists, infectious disease doctors, transplant physicians, hepatologists, NPs, nurses and PAs.
Learn More
Community & NGOs
Active with a number of organizations including international advocacy focusing on public policy in Vietnam, Philippines and Armenia.
Learn More
Patients & Caregivers
Clinical support, including consulting on provider-to-patient care and clinical follow-up via Epic My-Chart, telehealth and telemedicine.
Learn More
Photo & Video Gallery
-
Asian Pacific Health Foundation
-
HCC pathophysiology, treatments and mechanisms
-
Intro to Hepatology via APHF and Skaggs School of Pharmacy
-
A True Innovation in the Prevention of Hepatitis-B
-
APASL 2018 Interview with Hepatology Digest
-
CURRENT MANAGEMENT OF ALCOHOLIC HEPATITIS
-
Int'l GI and Hepatology Workshop - Hanoi
-
Understanding Your Hepatitis B (Hep B) Test Results
-
Hepatitis Delta - The Hidden Epidemic
-
Quantitative HBsAg and its Role in Chronic Hepatitis B Patient Management
-
Hepatocellular Carcinoma Podcast Presented by Dr Robert Gish
-
PATIENT ED - TREATMENT OPTIONS FOR LIVER CANCER by Dr. Robert Gish
-
CIRRHOSIS (LIVER SCARRING) by Dr. Robert Gish
-
HEPATITIS B (HBV) by Dr. Robert Gish
-
HEPATITIS C (HCV) by Dr. Robert Gish
-
NASH (FATTY LIVER) by Dr. Robert Gish
-
LIVER BIOPSY by Dr. Robert Gish
-
BENIGN (NON-CANCEROUS) LIVER TUMORS by Dr. Robert Gish
-
LIVER CANCER, HEPATOCELLULAR CARCINOMA, AND HEPATOMA by Dr. Robert Gish
-
AUTOIMMUNE HEPATITIS by Dr. Robert Gish
-
TIPSS (transjugular intrahepatic portosystemic shunt) by Dr. Robert Gish
-
LIVER & NUTRITION IN CIRRHOSIS by Dr. Robert Gish
-
Voices: Dr. Robert Gish, Hepatitis B and C are the leading causes of liver cancer
-
ADVANCED HCC - Management Srategies for Emerging Targeted Therapies
-
HCC: Evolving Screening and Surveillance
-
Value of Genetic Testing and Second-Line Approaches
-
New Approaches to Measuring Response
-
Adjuvant and Combination Therapies for HCC
-
Asian Americans Encouraged to Test for Hepatitis B
-
Hepatitis A: CDC Viral Hepatitis Serology Training
-
Hepatitis B: CDC Viral Hepatitis Serology Training
-
Hepatitis B Serology Fact Sheet
-
Hepatitis C: CDC Viral Hepatitis Serology Training
-
Hepatitis D: CDC Viral Hepatitis Serology Training
-
Hepatitis E: CDC Viral Hepatitis Serology Training
Contact Dr. Robert Gish
Important Information
Please Read Before You Send your Message.
You should be aware of the general risks of transmitting information over the Internet, which may not use encryption. You should therefore not share any personal medical information that you would wish to be held confidential in a physician/patient or similar clinical relationship.
The information contained on this website is not intended, should not substitute for, or be used instead of, a clinical or therapeutic relationship with a health care professional who is fully familiar with the specifics of your case. The information on this site may assist you in your personal, general research but none of it constitutes the practice of medicine or any other health care profession.
Nothing in this site is intended as a recommendation or endorsement of any specific tests, products, procedures, healthcare provider, opinions, or other information that may be mentioned in this site. Any reliance on any information provided by the website personnel, others appearing on the site at the invitation of the website and/or other visitors to the site is solely at the user's risk.
E-mail correspondence with Dr. Robert G. Gish Consultants, LLC or any of its employees, or agents, does not create a physician/patient relationship between us or cause Dr. Gish to create or retain any medical records about you, monitor your care, or communicate with your own health care provider.
Always seek the advice of your physician or other qualified health care provider with any questions you have regarding your medical care. If you suspect that you may have a medical condition, or are seeking medical advice or treatment, we recommend that you consult a qualified health professional as soon as possible.